+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Discovery Informatics Market - Global Forecast 2026-2032- Product Image
Drug Discovery Informatics Market - Global Forecast 2026-2032- Product Image
Sale

Drug Discovery Informatics Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5887835
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Drug Discovery Informatics Market is projected to reach USD 3.88 Billion in 2026. It is expected to continue growing at a CAGR of 10.21%, reaching USD 6.95 Billion by 2032.

Drug Discovery Informatics: Executive Overview

Drug discovery informatics comprises the software, data infrastructure, analytical workflows, and computational methods used to support target identification, compound design, screening, preclinical evaluation, and translational research. Its role is expanding as pharmaceutical, biotechnology, academic, and public-sector laboratories seek more reproducible decisions across increasingly complex biological and chemical datasets. The field connects scientific data management with modeling, visualization, laboratory automation, and collaboration, making interoperability and evidence quality central to research performance.

From Isolated Tools to Connected Discovery Workflows

The landscape is shifting from fragmented, project-specific applications toward connected workflows spanning experimental design, data capture, analysis, and knowledge reuse. Cloud-enabled collaboration, standardized data models, electronic laboratory records, automation, and improved integration with scientific instruments are reducing manual handoffs while increasing the importance of governance. Organizations are also placing greater emphasis on explainability, validation, cybersecurity, and auditability as computational outputs increasingly influence compound prioritization and development decisions.

Artificial Intelligence Raises the Value of High-Quality Data

Artificial intelligence is affecting drug discovery informatics through virtual screening, molecular property prediction, structure-based design, generative chemistry, image analysis, biomarker discovery, and literature intelligence. Its cumulative impact depends less on model availability than on the quality, provenance, diversity, and accessibility of training data. Effective adoption therefore requires curated datasets, robust validation, human scientific oversight, reproducible pipelines, and controls for bias, data leakage, model drift, and misleading predictions. AI is most valuable when embedded in interpretable workflows that allow researchers to connect predictions with experimental evidence.

Regional Insights: Uneven Adoption with Shared Infrastructure Priorities

North America benefits from deep pharmaceutical, biotechnology, academic, and technology ecosystems, supporting advanced computational research and cloud adoption. Europe emphasizes data governance, cross-border collaboration, interoperability, and responsible use within a comparatively structured regulatory environment. Asia-Pacific combines rapidly expanding research capacity with strong investment in digital laboratories, automation, and AI, although maturity varies across economies. Latin America is developing informatics capabilities through academic, public, and private collaborations, with infrastructure and specialist availability remaining important considerations. The Middle East is strengthening research and innovation platforms, often through centralized digital initiatives, while Africa presents substantial opportunities for capacity building, locally relevant datasets, and collaborative research infrastructure.

Group Insights: Policy Alignment and Research Collaboration Shape Progress

ASEAN economies are advancing regional research connectivity while managing differences in infrastructure, standards, and workforce capabilities. BRICS members bring significant scientific and industrial diversity, creating opportunities for shared platforms and data collaboration alongside complex governance requirements. The European Union is strongly influenced by harmonized data, privacy, research, and AI policy considerations. G7 members generally combine mature research institutions with high expectations for security, validation, and responsible innovation. GCC countries are building digitally enabled research ecosystems through investment in infrastructure and talent, while NATO members place additional emphasis on resilience, secure collaboration, and protection of sensitive information.

Country Insights: Distinct Capabilities and Adoption Conditions

Australia combines strong biomedical research with opportunities to improve distributed data connectivity. Brazil is expanding computational biology and translational research while addressing infrastructure and specialist-training needs. Canada benefits from advanced life-science research and collaborative public institutions, with interoperability remaining important. China is developing large-scale scientific computing, AI, and pharmaceutical research capabilities within a distinctive data and regulatory environment. France, Germany, Italy, and Spain contribute established research and industrial bases, with adoption shaped by European data and compliance expectations. India offers a broad technical workforce and growing life-science activity, while Japan and South Korea bring sophisticated technology and manufacturing ecosystems. Mexico is strengthening research and digital capacity through collaboration. Russia retains scientific and computational capabilities but faces constraints linked to international access and collaboration. The United Kingdom and United States remain influential in computational biology, biomedical research, and informatics innovation, with strong attention to data governance and translational outcomes.

Action Priorities for Leaders Building Scalable Informatics

Industry leaders should begin with a governed data foundation that defines ownership, provenance, quality controls, access rights, and common vocabularies across research functions. They should prioritize interoperable architectures rather than isolated applications, connect informatics with laboratory automation where appropriate, and establish validation pathways for analytical and AI-enabled outputs. Workforce planning should combine domain scientists, data engineers, software specialists, and regulatory expertise. Partnerships with research institutions can expand capabilities, but agreements should clearly address data rights, security, reproducibility, and publication. Finally, leadership teams should evaluate initiatives using operational measures such as cycle-time reduction, data reuse, reproducibility, model performance, and successful experimental confirmation.

Research Methodology: Evidence-Led Market Interpretation

This executive summary applies a structured qualitative assessment of drug discovery informatics, focusing on technologies, workflows, adoption conditions, governance requirements, and regional or institutional capabilities. Insights are organized across the specified regions, country groupings, and countries to identify common patterns and meaningful differences. The analysis distinguishes established informatics functions from emerging AI-enabled applications and emphasizes verifiable themes such as interoperability, data quality, automation, regulatory alignment, workforce capability, and research collaboration. No market estimates, market shares, forecasts, or company-specific claims are used.

Conclusion: Informatics as Core Discovery Infrastructure

Drug discovery informatics is becoming foundational to how research organizations generate, connect, interpret, and reuse scientific evidence. The strongest outcomes will come from treating informatics as an enterprise capability rather than a collection of disconnected tools. Organizations that combine trusted data, interoperable systems, validated analytics, responsible AI, skilled teams, and secure collaboration will be better positioned to improve discovery decisions and translate computational insight into experimentally supported progress.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Drug Discovery Informatics Market, by Component
7.1. Introduction
7.2. Services
7.2.1. Consulting
7.2.2. Integration
7.2.3. Support And Maintenance
7.3. Software
7.3.1. Bioinformatics
7.3.1.1. Genomics Informatics
7.3.1.2. Proteomics Informatics
7.3.1.3. Transcriptomics Informatics
7.3.2. Cheminformatics
7.3.2.1. Molecular Docking
7.3.2.2. Qsar Modeling
7.3.2.3. Virtual Screening
8. Drug Discovery Informatics Market, by Therapeutic Area
8.1. Introduction
8.2. Cardiovascular Diseases
8.3. Infectious Diseases
8.4. Metabolic Disorders
8.5. Neuroscience
8.6. Oncology
9. Drug Discovery Informatics Market, by Application
9.1. Introduction
9.2. Admet Prediction
9.2.1. Metabolism Prediction
9.2.2. Pharmacokinetics Prediction
9.2.3. Toxicity Prediction
9.3. Lead Discovery
9.3.1. High Throughput Screening Informatics
9.3.2. Hit To Lead Informatics
9.3.3. Virtual Screening Informatics
9.4. Molecular Modeling Simulation
9.4.1. Molecular Dynamics
9.4.2. Qsar Modeling
9.4.3. Structure Based Design
9.5. Target Identification
9.5.1. Genomic Analysis
9.5.2. Proteomic Analysis
9.5.3. Target Validation Informatics
10. Drug Discovery Informatics Market, by End User
10.1. Introduction
10.2. Academic Research Institutes
10.3. Contract Research Organizations
10.4. Pharmaceutical Biotechnology Companies
11. Drug Discovery Informatics Market, by Deployment
11.1. Introduction
11.2. Cloud
11.3. On Premise
12. Drug Discovery Informatics Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Drug Discovery Informatics Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Drug Discovery Informatics Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Accenture plc
16.2. Agilent Technologies, Inc.
16.3. Aragen Life Sciences Ltd.
16.4. Boehringer Ingelheim International GmbH
16.5. Cadence Design Systems, Inc.
16.6. Certara, Inc.
16.7. Charles River Laboratories International, Inc.
16.8. ChemAxon Ltd.
16.9. Cognizant Technology Solutions Corporation
16.10. Collaborative Drug Discovery, Inc.
16.11. Crown Bioscience International
16.12. Dassault Systèmes SE
16.13. Eurofins Scientific SE
16.14. Evotec SE
16.15. Illumina, Inc.
16.16. Infosys Limited
16.17. Insilico Medicine, Inc.
16.18. International Business Machines Corporation
16.19. Jubilant Biosys Limited
16.20. Oracle Corporation
16.21. Revvity, Inc.
16.22. Schrödinger, Inc.
16.23. Selvita S.A.
16.24. Thermo Fisher Scientific Inc.
16.25. WuXi AppTec Co., Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Drug Discovery Informatics Market, Years Considered for the Study
FIGURE 2. Global Drug Discovery Informatics Market, Research Design
FIGURE 3. Global Drug Discovery Informatics Market, Research Framework
FIGURE 4. Global Drug Discovery Informatics Market, Data Triangulation
FIGURE 5. Global Drug Discovery Informatics Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Drug Discovery Informatics Market Size, by Component, 2025 vs 2032 (%)
FIGURE 7. Global Drug Discovery Informatics Market Size, by Component, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Drug Discovery Informatics Market Size, by Therapeutic Area, 2025 vs 2032 (%)
FIGURE 9. Global Drug Discovery Informatics Market Size, by Therapeutic Area, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Drug Discovery Informatics Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Drug Discovery Informatics Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Drug Discovery Informatics Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Drug Discovery Informatics Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Drug Discovery Informatics Market Size, by Deployment, 2025 vs 2032 (%)
FIGURE 15. Global Drug Discovery Informatics Market Size, by Deployment, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Drug Discovery Informatics Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Drug Discovery Informatics Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Drug Discovery Informatics Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Drug Discovery Informatics Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Drug Discovery Informatics Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Drug Discovery Informatics Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Drug Discovery Informatics Market Segmentation & Coverage
TABLE 2. Global Drug Discovery Informatics Market Size, 2017-2032 (USD Million)
TABLE 3. Global Drug Discovery Informatics Market Size, by Component, 2017-2032 (USD Million)
TABLE 4. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Consulting Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Consulting Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Consulting Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Integration Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Integration Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Integration Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Support And Maintenance Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Support And Maintenance Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Support And Maintenance Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Bioinformatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Bioinformatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Bioinformatics Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Genomics Informatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Genomics Informatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Genomics Informatics Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Proteomics Informatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Proteomics Informatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Proteomics Informatics Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Transcriptomics Informatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Transcriptomics Informatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Transcriptomics Informatics Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Cheminformatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Cheminformatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Cheminformatics Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Molecular Docking Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Molecular Docking Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Molecular Docking Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Qsar Modeling Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Qsar Modeling Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Qsar Modeling Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Virtual Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Virtual Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Virtual Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Drug Discovery Informatics Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 44. Global Cardiovascular Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Cardiovascular Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Cardiovascular Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Metabolic Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Metabolic Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Metabolic Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Neuroscience Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Neuroscience Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Neuroscience Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Drug Discovery Informatics Market Size, by Application, 2017-2032 (USD Million)
TABLE 60. Global Admet Prediction Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Admet Prediction Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Admet Prediction Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Metabolism Prediction Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Metabolism Prediction Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Metabolism Prediction Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Pharmacokinetics Prediction Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Pharmacokinetics Prediction Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Pharmacokinetics Prediction Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Toxicity Prediction Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Toxicity Prediction Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Toxicity Prediction Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Lead Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Lead Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Lead Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global High Throughput Screening Informatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global High Throughput Screening Informatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global High Throughput Screening Informatics Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Hit To Lead Informatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Hit To Lead Informatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Hit To Lead Informatics Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Virtual Screening Informatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Virtual Screening Informatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Virtual Screening Informatics Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Molecular Modeling Simulation Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Molecular Modeling Simulation Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Molecular Modeling Simulation Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Molecular Dynamics Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Molecular Dynamics Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Molecular Dynamics Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Qsar Modeling Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Qsar Modeling Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Qsar Modeling Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Structure Based Design Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Structure Based Design Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Structure Based Design Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Target Identification Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Target Identification Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Target Identification Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Genomic Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Genomic Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Genomic Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Proteomic Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Proteomic Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Proteomic Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Target Validation Informatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Target Validation Informatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Target Validation Informatics Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Drug Discovery Informatics Market Size, by End User, 2017-2032 (USD Million)
TABLE 109. Global Academic Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Academic Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Academic Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Pharmaceutical Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Pharmaceutical Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Pharmaceutical Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Drug Discovery Informatics Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 119. Global Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global On Premise Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global On Premise Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global On Premise Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Drug Discovery Informatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Drug Discovery Informatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Drug Discovery Informatics Market Size, by Component, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Drug Discovery Informatics Market Size, by Services, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Drug Discovery Informatics Market Size, by Software, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Drug Discovery Informatics Market Size, by Bioinformatics, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Drug Discovery Informatics Market Size, by Cheminformatics, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Drug Discovery Informatics Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Drug Discovery Informatics Market Size, by Application, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Drug Discovery Informatics Market Size, by Admet Prediction, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific Drug Discovery Informatics Market Size, by Lead Discovery, 2017-2032 (USD Million)
TABLE 136. Asia-Pacific Drug Discovery Informatics Market Size, by Molecular Modeling Simulation, 2017-2032 (USD Million)
TABLE 137. Asia-Pacific Drug Discovery Informatics Market Size, by Target Identification, 2017-2032 (USD Million)
TABLE 138. Asia-Pacific Drug Discovery Informatics Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. Asia-Pacific Drug Discovery Informatics Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 140. North America Drug Discovery Informatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. North America Drug Discovery Informatics Market Size, by Component, 2017-2032 (USD Million)
TABLE 142. North America Drug Discovery Informatics Market Size, by Services, 2017-2032 (USD Million)
TABLE 143. North America Drug Discovery Informatics Market Size, by Software, 2017-2032 (USD Million)
TABLE 144. North America Drug Discovery Informatics Market Size, by Bioinformatics, 2017-2032 (USD Million)
TABLE 145. North America Drug Discovery Informatics Market Size, by Cheminformatics, 2017-2032 (USD Million)
TABLE 146. North America Drug Discovery Informatics Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 147. North America Drug Discovery Informatics Market Size, by Application, 2017-2032 (USD Million)
TABLE 148. North America Drug Discovery Informatics Market Size, by Admet Prediction, 2017-2032 (USD Million)
TABLE 149. North America Drug Discovery Informatics Market Size, by Lead Discovery, 2017-2032 (USD Million)
TABLE 150. North America Drug Discovery Informatics Market Size, by Molecular Modeling Simulation, 2017-2032 (USD Million)
TABLE 151. North America Drug Discovery Informatics Market Size, by Target Identification, 2017-2032 (USD Million)
TABLE 152. North America Drug Discovery Informatics Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. North America Drug Discovery Informatics Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 154. Latin America Drug Discovery Informatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Latin America Drug Discovery Informatics Market Size, by Component, 2017-2032 (USD Million)
TABLE 156. Latin America Drug Discovery Informatics Market Size, by Services, 2017-2032 (USD Million)
TABLE 157. Latin America Drug Discovery Informatics Market Size, by Software, 2017-2032 (USD Million)
TABLE 158. Latin America Drug Discovery Informatics Market Size, by Bioinformatics, 2017-2032 (USD Million)
TABLE 159. Latin America Drug Discovery Informatics Market Size, by Cheminformatics, 2017-2032 (USD Million)
TABLE 160. Latin America Drug Discovery Informatics Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 161. Latin America Drug Discovery Informatics Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. Latin America Drug Discovery Informatics Market Size, by Admet Prediction, 2017-2032 (USD Million)
TABLE 163. Latin America Drug Discovery Informatics Market Size, by Lead Discovery, 2017-2032 (USD Million)
TABLE 164. Latin America Drug Discovery Informatics Market Size, by Molecular Modeling Simulation, 2017-2032 (USD Million)
TABLE 165. Latin America Drug Discovery Informatics Market Size, by Target Identification, 2017-2032 (USD Million)
TABLE 166. Latin America Drug Discovery Informatics Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. Latin America Drug Discovery Informatics Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 168. Europe Drug Discovery Informatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 169. Europe Drug Discovery Informatics Market Size, by Component, 2017-2032 (USD Million)
TABLE 170. Europe Drug Discovery Informatics Market Size, by Services, 2017-2032 (USD Million)
TABLE 171. Europe Drug Discovery Informatics Market Size, by Software, 2017-2032 (USD Million)
TABLE 172. Europe Drug Discovery Informatics Market Size, by Bioinformatics, 2017-2032 (USD Million)
TABLE 173. Europe Drug Discovery Informatics Market Size, by Cheminformatics, 2017-2032 (USD Million)
TABLE 174. Europe Drug Discovery Informatics Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 175. Europe Drug Discovery Informatics Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. Europe Drug Discovery Informatics Market Size, by Admet Prediction, 2017-2032 (USD Million)
TABLE 177. Europe Drug Discovery Informatics Market Size, by Lead Discovery, 2017-2032 (USD Million)
TABLE 178. Europe Drug Discovery Informatics Market Size, by Molecular Modeling Simulation, 2017-2032 (USD Million)
TABLE 179. Europe Drug Discovery Informatics Market Size, by Target Identification, 2017-2032 (USD Million)
TABLE 180. Europe Drug Discovery Informatics Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. Europe Drug Discovery Informatics Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 182. Middle East Drug Discovery Informatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 183. Middle East Drug Discovery Informatics Market Size, by Component, 2017-2032 (USD Million)
TABLE 184. Middle East Drug Discovery Informatics Market Size, by Services, 2017-2032 (USD Million)
TABLE 185. Middle East Drug Discovery Informatics Market Size, by Software, 2017-2032 (USD Million)
TABLE 186. Middle East Drug Discovery Informatics Market Size, by Bioinformatics, 2017-2032 (USD Million)
TABLE 187. Middle East Drug Discovery Informatics Market Size, by Cheminformatics, 2017-2032 (USD Million)
TABLE 188. Middle East Drug Discovery Informatics Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 189. Middle East Drug Discovery Informatics Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. Middle East Drug Discovery Informatics Market Size, by Admet Prediction, 2017-2032 (USD Million)
TABLE 191. Middle East Drug Discovery Informatics Market Size, by Lead Discovery, 2017-2032 (USD Million)
TABLE 192. Middle East Drug Discovery Informatics Market Size, by Molecular Modeling Simulation, 2017-2032 (USD Million)
TABLE 193. Middle East Drug Discovery Informatics Market Size, by Target Identification, 2017-2032 (USD Million)
TABLE 194. Middle East Drug Discovery Informatics Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. Middle East Drug Discovery Informatics Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 196. Africa Drug Discovery Informatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 197. Africa Drug Discovery Informatics Market Size, by Component, 2017-2032 (USD Million)
TABLE 198. Africa Drug Discovery Informatics Market Size, by Services, 2017-2032 (USD Million)
TABLE 199. Africa Drug Discovery Informatics Market Size, by Software, 2017-2032 (USD Million)
TABLE 200. Africa Drug Discovery Informatics Market Size, by Bioinformatics, 2017-2032 (USD Million)
TABLE 201. Africa Drug Discovery Informatics Market Size, by Cheminformatics, 2017-2032 (USD Million)
TABLE 202. Africa Drug Discovery Informatics Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 203. Africa Drug Discovery Informatics Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. Africa Drug Discovery Informatics Market Size, by Admet Prediction, 2017-2032 (USD Million)
TABLE 205. Africa Drug Discovery Informatics Market Size, by Lead Discovery, 2017-2032 (USD Million)
TABLE 206. Africa Drug Discovery Informatics Market Size, by Molecular Modeling Simulation, 2017-2032 (USD Million)
TABLE 207. Africa Drug Discovery Informatics Market Size, by Target Identification, 2017-2032 (USD Million)
TABLE 208. Africa Drug Discovery Informatics Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. Africa Drug Discovery Informatics Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 210. Global Drug Discovery Informatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 211. ASEAN Drug Discovery Informatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 212. ASEAN Drug Discovery Informatics Market Size, by Component, 2017-2032 (USD Million)
TABLE 213. ASEAN Drug Discovery Informatics Market Size, by Services, 2017-2032 (USD Million)
TABLE 214. ASEAN Drug Discovery Informatics Market Size, by Software, 2017-2032 (USD Million)
TABLE 215. ASEAN Drug Discovery Informatics Market Size, by Bioinformatics, 2017-2032 (USD Million)
TABLE 216. ASEAN Drug Discovery Informatics Market Size, by Cheminformatics, 2017-2032 (USD Million)
TABLE 217. ASEAN Drug Discovery Informatics Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 218. ASEAN Drug Discovery Informatics Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. ASEAN Drug Discovery Informatics Market Size, by Admet Prediction, 2017-2032 (USD Million)
TABLE 220. ASEAN Drug Discovery Informatics Market Size, by Lead Discovery, 2017-2032 (USD Million)
TABLE 221. ASEAN Drug Discovery Informatics Market Size, by Molecular Modeling Simulation, 2017-2032 (USD Million)
TABLE 222. ASEAN Drug Discovery Informatics Market Size, by Target Identification, 2017-2032 (USD Million)
TABLE 223. ASEAN Drug Discovery Informatics Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. ASEAN Drug Discovery Informatics Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 225. GCC Drug Discovery Informatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 226. GCC Drug Discovery Informatics Market Size, by Component, 2017-2032 (USD Million)
TABLE 227. GCC Drug Discovery Informatics Market Size, by Services, 2017-2032 (USD Million)
TABLE 228. GCC Drug Discovery Informatics Market Size, by Software, 2017-2032 (USD Million)
TABLE 229. GCC Drug Discovery Informatics Market Size, by Bioinformatics, 2017-2032 (USD Million)
TABLE 230. GCC Drug Discovery Informatics Market Size, by Cheminformatics, 2017-2032 (USD Million)
TABLE 231. GCC Drug Discovery Informatics Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 232. GCC Drug Discovery Informatics Market Size, by Application, 2017-2032 (USD Million)
TABLE 233. GCC Drug Discovery Informatics Market Size, by Admet Prediction, 2017-2032 (USD Million)
TABLE 234. GCC Drug Discovery Informatics Market Size, by Lead Discovery, 2017-2032 (USD Million)
TABLE 235. GCC Drug Discovery Informatics Market Size, by Molecular Modeling Simulation, 2017-2032 (USD Million)
TABLE 236. GCC Drug Discovery Informatics Market Size, by Target Identification, 2017-2032 (USD Million)
TABLE 237. GCC Drug Discovery Informatics Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. GCC Drug Discovery Informatics Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 239. European Union Drug Discovery Informatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 240. European Union Drug Discovery Informatics Market Size, by Component, 2017-2032 (USD Million)
TABLE 241. European Union Drug Discovery Informatics Market Size, by Services, 2017-2032 (USD Million)
TABLE 242. European Union Drug Discovery Informatics Market Size, by Software, 2017-2032 (USD Million)
TABLE 243. European Union Drug Discovery Informatics Market Size, by Bioinformatics, 2017-2032 (USD Million)
TABLE 244. European Union Drug Discovery Informatics Market Size, by Cheminformatics, 2017-2032 (USD Million)
TABLE 245. European Union Drug Discovery Informatics Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 246. European Union Drug Discovery Informatics Market Size, by Application, 2017-2032 (USD Million)
TABLE 247. European Union Drug Discovery Informatics Market Size, by Admet Prediction, 2017-2032 (USD Million)
TABLE 248. European Union Drug Discovery Informatics Market Size, by Lead Discovery, 2017-2032 (USD Million)
TABLE 249. European Union Drug Discovery Informatics Market Size, by Molecular Modeling Simulation, 2017-2032 (USD Million)
TABLE 250. European Union Drug Discovery Informatics Market Size, by Target Identification, 2017-2032 (USD Million)
TABLE 251. European Union Drug Discovery Informatics Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. European Union Drug Discovery Informatics Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 253. BRICS Drug Discovery Informatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 254. BRICS Drug Discovery Informatics Market Size, by Component, 2017-2032 (USD Million)
TABLE 255. BRICS Drug Discovery Informatics Market Size, by Services, 2017-2032 (USD Million)
TABLE 256. BRICS Drug Discovery Informatics Market Size, by Software, 2017-2032 (USD Million)
TABLE 257. BRICS Drug Discovery Informatics Market Size, by Bioinformatics, 2017-2032 (USD Million)
TABLE 258. BRICS Drug Discovery Informatics Market Size, by Cheminformatics, 2017-2032 (USD Million)
TABLE 259. BRICS Drug Discovery Informatics Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 260. BRICS Drug Discovery Informatics Market Size, by Application, 2017-2032 (USD Million)
TABLE 261. BRICS Drug Discovery Informatics Market Size, by Admet Prediction, 2017-2032 (USD Million)
TABLE 262. BRICS Drug Discovery Informatics Market Size, by Lead Discovery, 2017-2032 (USD Million)
TABLE 263. BRICS Drug Discovery Informatics Market Size, by Molecular Modeling Simulation, 2017-2032 (USD Million)
TABLE 264. BRICS Drug Discovery Informatics Market Size, by Target Identification, 2017-2032 (USD Million)
TABLE 265. BRICS Drug Discovery Informatics Market Size, by End User, 2017-2032 (USD Million)
TABLE 266. BRICS Drug Discovery Informatics Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 267. G7 Drug Discovery Informatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 268. G7 Drug Discovery Informatics Market Size, by Component, 2017-2032 (USD Million)
TABLE 269. G7 Drug Discovery Informatics Market Size, by Services, 2017-2032 (USD Million)
TABLE 270. G7 Drug Discovery Informatics Market Size, by Software, 2017-2032 (USD Million)
TABLE 271. G7 Drug Discovery Informatics Market Size, by Bioinformatics, 2017-2032 (USD Million)
TABLE 272. G7 Drug Discovery Informatics Market Size, by Cheminformatics, 2017-2032 (USD Million)
TABLE 273. G7 Drug Discovery Informatics Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 274. G7 Drug Discovery Informatics Market Size, by Application, 2017-2032 (USD Million)
TABLE 275. G7 Drug Discovery Informatics Market Size, by Admet Prediction, 2017-2032 (USD Million)
TABLE 276. G7 Drug Discovery Informatics Market Size, by Lead Discovery, 2017-2032 (USD Million)
TABLE 277. G7 Drug Discovery Informatics Market Size, by Molecular Modeling Simulation, 2017-2032 (USD Million)
TABLE 278. G7 Drug Discovery Informatics Market Size, by Target Identification, 2017-2032 (USD Million)
TABLE 279. G7 Drug Discovery Informatics Market Size, by End User, 2017-2032 (USD Million)
TABLE 280. G7 Drug Discovery Informatics Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 281. NATO Drug Discovery Informatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 282. NATO Drug Discovery Informatics Market Size, by Component, 2017-2032 (USD Million)
TABLE 283. NATO Drug Discovery Informatics Market Size, by Services, 2017-2032 (USD Million)
TABLE 284. NATO Drug Discovery Informatics Market Size, by Software, 2017-2032 (USD Million)
TABLE 285. NATO Drug Discovery Informatics Market Size, by Bioinformatics, 2017-2032 (USD Million)
TABLE 286. NATO Drug Discovery Informatics Market Size, by Cheminformatics, 2017-2032 (USD Million)
TABLE 287. NATO Drug Discovery Informatics Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 288. NATO Drug Discovery Informatics Market Size, by Application, 2017-2032 (USD Million)
TABLE 289. NATO Drug Discovery Informatics Market Size, by Admet Prediction, 2017-2032 (USD Million)
TABLE 290. NATO Drug Discovery Informatics Market Size, by Lead Discovery, 2017-2032 (USD Million)
TABLE 291. NATO Drug Discovery Informatics Market Size, by Molecular Modeling Simulation, 2017-2032 (USD Million)
TABLE 292. NATO Drug Discovery Informatics Market Size, by Target Identification, 2017-2032 (USD Million)
TABLE 293. NATO Drug Discovery Informatics Market Size, by End User, 2017-2032 (USD Million)
TABLE 294. NATO Drug Discovery Informatics Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 295. Global Drug Discovery Informatics Market Size, by Country, 2017-2032 (USD Million)
TABLE 296. United States Drug Discovery Informatics Market Size, 2017-2032 (USD Million)
TABLE 297. United States Drug Discovery Informatics Market Size, by Component, 2017-2032 (USD Million)
TABLE 298. United States Drug Discovery Informatics Market Size, by Services, 2017-2032 (USD Million)
TABLE 299. United States Drug Discovery Informatics Market Size, by Software, 2017-2032 (USD Million)
TABLE 300. United States Drug Discovery Informatics Market Size, by Bioinformatics, 2017-2032 (USD Million)
TABLE 301. United States Drug Discovery Informatics Market Size, by Cheminformatics, 2017-2032 (USD Million)
TABLE 302. United States Drug Discovery Informatics Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 303. United States Drug Discovery Informatics Market Size, by Application, 2017-2032 (USD Million)
TABLE 304. United States Drug Discovery Informatics Market Size, by Admet Prediction, 2017-2032 (USD Million)
TABLE 305. United States Drug Discovery Informatics Market Size, by Lead Discovery, 2017-2032 (USD Million)
TABLE 306. United States Drug Discovery Informatics Market Size, by Molecular Modeling Simulation, 2017-2032 (USD Million)
TABLE 307. United States Drug Discovery Informatics Market Size, by Target Identification, 2017-2032 (USD Million)
TABLE 308. United States Drug Discovery Informatics Market Size, by End User, 2017-2032 (USD Million)
TABLE 309. United States Drug Discovery Informatics Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 310. Canada Drug Discovery Informatics Market Size, 2017-2032 (USD Million)
TABLE 311. Canada Drug Discovery Informatics Market Size, by Component, 2017-2032 (USD Million)
TABLE 312. Canada Drug Discovery Informatics Market Size, by Services, 2017-2032 (USD Million)
TABLE 313. Canada Drug Discovery Informatics Market Size, by Software, 2017-2032 (USD Million)
TABLE 314. Canada Drug Discovery Informatics Market Size, by Bioinformatics, 2017-2032 (USD Million)
TABLE 315. Canada Drug Discovery Informatics Market Size, by Cheminformatics, 2017-2032 (USD Million)
TABLE 316. Canada Drug Discovery Informatics Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 317. Canada Drug Discovery Informatics Market Size, by Application, 2017-2032 (USD Million)
TABLE 318. Canada Drug Discovery Informatics Market Size, by Admet Prediction, 2017-2032 (USD Million)
TABLE 319. Canada Drug Discovery Informatics Market Size, by Lead Discovery, 2017-2032 (USD Million)
TABLE 320. Canada Drug Discovery Informatics Market Size, by Molecular Modeling Simulation, 2017-2032 (USD Million)
TABLE 321. Canada Drug Discovery Informatics Market Size, by Target Identification, 2017-2032 (USD Million)
TABLE 322. Canada Drug Discovery Informatics Market Size, by End User, 2017-2032 (USD Million)
TABLE 323. Canada Drug Discovery Informatics Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 324. Mexico Drug Discovery Informatics Market Size, 2017-2032 (USD Million)
TABLE 325. Mexico Drug Discovery Informatics Market Size, by Component, 2017-2032 (USD Million)
TABLE 326. Mexico Drug Discovery Informatics Market Size, by Services, 2017-2032 (USD Million)
TABLE 327. Mexico Drug Discovery Informatics Market Size, by Software, 2017-2032 (USD Million)
TABLE 328. Mexico Drug Discovery Informatics Market Size, by Bioinformatics, 2017-2032 (USD Million)
TABLE 329. Mexico Drug Discovery Informatics Market Size, by Cheminformatics, 2017-2032 (USD Million)
TABLE 330. Mexico Drug Discovery Informatics Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 331. Mexico Drug Discovery Informatics Market Size, by Application, 2017-2032 (USD Million)
TABLE 332. Mexico Drug Discovery Informatics Market Size, by Admet Prediction, 2017-2032 (USD Million)
TABLE 333. Mexico Drug Discovery Informatics Market Size, by Lead Discovery, 2017-2032 (USD Million)
TABLE 334. Mexico Drug Discovery Informatics Market Size, by Molecular Modeling Simulation, 2017-2032 (USD Million)
TABLE 335. Mexico Drug Discovery Informatics Market Size, by Target Identification, 2017-2032 (USD Million)
TABLE 336. Mexico Drug Discovery Informatics Market Size, by End User, 2017-2032 (USD Million)
TABLE 337. Mexico Drug Discovery Informatics Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 338. Brazil Drug Discovery Informatics Market Size, 2017-2032 (USD Million)
TABLE 339. Brazil Drug Discovery Informatics Market Size, by Component, 2017-2032 (USD Million)
TABLE 340. Brazil Drug Discovery Informatics Market Size, by Services, 2017-2032 (USD Million)
TABLE 341. Brazil Drug Discovery Informatics Market Size, by Software, 2017-2032 (USD Million)
TABLE 342. Brazil Drug Discovery Informatics Market Size, by Bioinformatics, 2

Companies Mentioned

  • Accenture plc
  • Agilent Technologies, Inc.
  • Aragen Life Sciences Ltd.
  • Boehringer Ingelheim International GmbH
  • Cadence Design Systems, Inc.
  • Certara, Inc.
  • Charles River Laboratories International, Inc.
  • ChemAxon Ltd.
  • Cognizant Technology Solutions Corporation
  • Collaborative Drug Discovery, Inc.
  • Crown Bioscience International
  • Dassault Systèmes SE
  • Eurofins Scientific SE
  • Evotec SE
  • Illumina, Inc.
  • Infosys Limited
  • Insilico Medicine, Inc.
  • International Business Machines Corporation
  • Jubilant Biosys Limited
  • Oracle Corporation
  • Revvity, Inc.
  • Schrödinger, Inc.
  • Selvita S.A.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.

Related Topics

Related Reports

Drug Discovery Informatics - Global Strategic Business Report - Product Image

Drug Discovery Informatics - Global Strategic Business Report

  • Report
  • 161 Pages
  • Global
From
Drug Discovery Informatics Market Report 2026 - Product Image

Drug Discovery Informatics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Drug Discovery Informatics Market Report by Workflow, Function, Mode, End User, and Region 2026-2034 - Product Image

Drug Discovery Informatics Market Report by Workflow, Function, Mode, End User, and Region 2026-2034

  • Report
  • 135 Pages
  • Global
From
Drug Discovery Informatics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Drug Discovery Informatics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Drug Discovery Informatics Market Insights, Competitive Landscape, and Market Forecast - 2033 - Product Image

Drug Discovery Informatics Market Insights, Competitive Landscape, and Market Forecast - 2033

  • Report
  • 200 Pages
  • Global
From

About the Market

Drug Discovery Informatics is a field of research that focuses on the development of software and databases to support the drug discovery process. It involves the integration of data from multiple sources, such as biological, chemical, and clinical data, to enable the identification of potential drug targets and the development of new drugs. Drug Discovery Informatics also includes the development of algorithms and software tools to analyze and interpret data, as well as the development of predictive models to identify potential drug candidates. Drug Discovery Informatics is an important part of the drug discovery process, as it enables the efficient and effective analysis of large amounts of data. It also helps to reduce the cost and time associated with drug discovery, as well as to improve the accuracy of drug discovery. Some companies in the Drug Discovery Informatics market include IBM, Microsoft, Oracle, Infor, and Accenture. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.